April 7, 2009 - Ziosoft Inc. today announced that it has received FDA 510(k) clearance to market cardiac function analysis and calcium scoring applications for use with the Ziostation thin-client advanced visualization system.
Both the cardiac function analysis and calcium scoring applications can be accessed throughout the enterprise on the Ziostation thin-client system and are designed to provide physicians with improved efficiency and real-time collaboration when assessing results from a CT cardiac scan.
Physicians can use the calcium scoring application to help determine whether a patient may be at increased risk for coronary artery disease. Ziosoft’s calcium scoring application features valuable tools such as concurrent reading of the calcium analysis adjacent to the original data set, which allows for efficient and precise analysis of data. The cardiac function application enables physicians to conduct a cardiac functional assessment and includes tools such as automatic left ventricle segmentation, peak filling rate (PFR) and peak ejection rate (PER) in addition to the standard functional assessment calculations. The cardiac function application also includes the capability to automatically generate “bulls-eye” maps and a time volume graph to aid in the physician’s evaluation.
For more information: www.ziosoftinc.com.
May 12, 2020 
